|
IFRD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.458200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.206600E-01 |
| Normal-vs-Stage2 |
6.276400E-01 |
| Normal-vs-Stage3 |
4.096000E-02 |
| Normal-vs-Stage4 |
2.959800E-01 |
| Stage1-vs-Stage2 |
4.279400E-01 |
| Stage1-vs-Stage3 |
2.505600E-02 |
| Stage1-vs-Stage4 |
3.527800E-01 |
| Stage2-vs-Stage3 |
3.471900E-02 |
| Stage2-vs-Stage4 |
2.080200E-01 |
| Stage3-vs-Stage4 |
4.255200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.420760E-01 |
| Normal-vs-AfricanAmerican |
2.629000E-01 |
| Normal-vs-Asian |
7.141200E-01 |
| Caucasian-vs-AfricanAmerican |
9.192400E-01 |
| Caucasian-vs-Asian |
6.948300E-02 |
| AfricanAmerican-vs-Asian |
1.610950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.745800E-01 |
| Normal-vs-Female |
3.934800E-01 |
| Male-vs-Female |
5.495200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.132000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.256000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.470420E-01 |
| Normal-vs-Age(81-100Yrs) |
2.115200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.595800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.933900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.084100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.226800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.317200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.570200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.45519999999555E-05 |
| Classical-VS-Follicular |
2.483600E-03 |
| Classical-VS-Other |
1.140820E-01 |
| Classical-VS-Normal |
2.469200E-01 |
| Tall-VS-Follicular |
8.63429999720111E-08 |
| Tall-VS-Other |
3.141900E-02 |
| Tall-VS-Normal |
6.12129999999489E-05 |
| Follicular-VS-Other |
9.933800E-01 |
| Follicular-VS-Normal |
8.096400E-02 |
| Other-VS-Normal |
3.193200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.791400E-01 |
| Normal-vs-N1 |
3.614200E-01 |
| N0-vs-N1 |
6.098000E-01 |
|
|
